Ironwood Pharmaceuticals, Inc. (IRWD)
USD 3.46
(-1.98%)
USD 3.46
(-1.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 183.42 Million | 273.76 Million | 261.89 Million | 168.83 Million | 10.72 Million | -70.88 Million |
| Net Income | -1 Billion | 175.06 Million | 528.44 Million | 106.17 Million | 21.5 Million | -282.36 Million |
| Depreciation & Amortization | 1.57 Million | 1.41 Million | 1.52 Million | 3.56 Million | 5.58 Million | 14.22 Million |
| Deferred income taxes | 72.63 Million | 65.73 Million | -333.29 Million | 6.59 Million | 35.93 Million | 159.11 Million |
| Stock-based compensation | 59.55 Million | 27.04 Million | 22.28 Million | 31.17 Million | 31.27 Million | 43.97 Million |
| Change in working capital | 11.27 Million | 2.82 Million | 17.73 Million | -941 Thousand | -99.99 Million | 7.61 Million |
| Other non-cash items | 1.06 Billion | 1.67 Million | 25.2 Million | 22.26 Million | 16.42 Million | -13.44 Million |
| Investing Cash Flow | -1.02 Billion | -136 Thousand | -265 Thousand | -1.84 Million | -11.14 Million | 88.86 Million |
| Investments in PPE | -273 Thousand | -136 Thousand | -265 Thousand | -1.84 Million | -7.18 Million | -8.62 Million |
| Acquisitions | -1.02 Billion | - | - | - | 268 Thousand | 1.56 Million |
| Investment purchases | - | - | - | - | - | -3.24 Million |
| Sales/Maturities of investments | - | - | - | - | - | 99.16 Million |
| Other Investing Activities | - | - | - | - | -4.22 Million | 1.56 Million |
| Financing Cash Flow | 277.16 Million | -237.55 Million | -4.55 Million | 18.54 Million | -1.18 Million | 30.07 Million |
| Debt repayment | -300 Million | -120.69 Million | - | - | -156.4 Million | -1.82 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -126.39 Million | -24.13 Million | - | - | - |
| Common Stock Issuance | 6.35 Million | 9.54 Million | 19.58 Million | 18.54 Million | 13.59 Million | 32.06 Million |
| Other Financing Activities | 570.8 Million | 111.15 Million | -4.55 Million | 18.54 Million | 141.62 Million | 31.89 Million |
| Accounts receivables | 924 Thousand | 7.99 Million | 7.71 Million | 4.09 Million | -68.89 Million | 1.2 Million |
| Accounts payables | 12.38 Million | -8.11 Million | -2.64 Million | -7.52 Million | -32.7 Million | 8.05 Million |
| Inventory | - | - | - | 648 Thousand | 725 Thousand | -806 Thousand |
| Other working capital | -2.02 Million | 2.94 Million | 12.66 Million | 1.84 Million | 875 Thousand | -842 Thousand |
| Cash at beginning of period | 657.45 Million | 621.86 Million | 364.78 Million | 179.24 Million | 180.84 Million | 132.79 Million |
| Cash at end of period | 92.15 Million | 657.93 Million | 621.86 Million | 364.78 Million | 179.24 Million | 180.84 Million |
| Capital Expenditure | -273 Thousand | -136 Thousand | -265 Thousand | -1.84 Million | -7.18 Million | -8.62 Million |
| Effect of forex changes on cash | -53 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -565.29 Million | 36.07 Million | 257.08 Million | 185.54 Million | -1.6 Million | 48.05 Million |
| Free Cash Flow | 183.15 Million | 273.62 Million | 261.63 Million | 166.99 Million | 3.53 Million | -79.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -860 Thousand | -4.16 Million | -1 Billion | -1.08 Million | 13.95 Million | -1.08 Billion |
| Depreciation & Amortization | 506 Thousand | 513 Thousand | 1.57 Million | 512 Thousand | 507 Thousand | 270 Thousand |
| Deferred income taxes | 13.25 Million | 6.05 Million | 72.63 Million | 31.32 Million | 14.25 Million | 10 Million |
| Stock-based compensation | 8.57 Million | 8.38 Million | 59.55 Million | 8.7 Million | 7.9 Million | 8.26 Million |
| Change in working capital | 11.4 Million | 33.57 Million | 11.27 Million | -8.54 Million | -4.74 Million | 14.96 Million |
| Other non-cash items | -1.74 Million | -34.54 Million | 1.06 Billion | 4.92 Million | 586 Thousand | 1.09 Billion |
| Investing Cash Flow | -58 Thousand | -68 Thousand | -1.02 Billion | -4.18 Million | -22.62 Million | -999.49 Million |
| Investments in PPE | -58 Thousand | -68 Thousand | -273 Thousand | -211 Thousand | -49 Thousand | - |
| Acquisitions | - | - | -1.02 Billion | -3.97 Million | -22.57 Million | -999.49 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -58 Thousand | - | - | 1.00 | -22.62 Million | -999.49 Million |
| Financing Cash Flow | -49.37 Million | -15.55 Million | 277.16 Million | -50.9 Million | -74.98 Million | 399.07 Million |
| Debt repayment | -50 Million | -25 Million | -300 Million | -22.7 Million | -75 Million | -397.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -616 Thousand | - | - | - | - |
| Common Stock Issuance | 749 Thousand | 10.06 Million | 6.35 Million | 998 Thousand | 12 Thousand | 1.36 Million |
| Other Financing Activities | -121 Thousand | -616 Thousand | 570.8 Million | -29.19 Million | -74.98 Million | 795.41 Million |
| Accounts receivables | 13.9 Million | 57.1 Million | 924 Thousand | -4.57 Million | -5.55 Million | -3.24 Million |
| Accounts payables | -1.99 Million | -12.52 Million | 12.38 Million | -12.54 Million | 6.59 Million | 17.62 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -502 Thousand | -11 Million | -2.02 Million | 8.57 Million | -5.78 Million | 578 Thousand |
| Cash at beginning of period | 121.54 Million | 92.15 Million | 657.45 Million | 110.95 Million | 176.61 Million | 742.07 Million |
| Cash at end of period | 105.52 Million | 121.54 Million | 92.15 Million | 92.15 Million | 111.46 Million | 176.61 Million |
| Capital Expenditure | -58 Thousand | -68 Thousand | -273 Thousand | -211 Thousand | -49 Thousand | - |
| Effect of forex changes on cash | -51 Thousand | 24 Thousand | -53 Thousand | -50 Thousand | -3000.00 | -34.96 Million |
| Net cash flow / Change in cash | -16.01 Million | 29.38 Million | -565.29 Million | -18.79 Million | -65.15 Million | -565.45 Million |
| Free Cash Flow | 33.4 Million | 44.91 Million | 183.15 Million | 35.62 Million | 32.41 Million | 34.96 Million |
024070
UNTN
1304
KDSI
0J4V
5126